Elanco Animal Health Incorporated · ELAN · Next earnings
Elanco Animal Health Incorporated reports Friday, Nov 6, 2026
ELAN reports before market open with consensus EPS at $0.20 and revenue at $1.21B. Last quarter: Elanco lifts 2026 outlook as innovation products drive Q3 growth
What the street expects
Consensus for the coming reportWhere ELAN left off: FY2026 Q3
Full reportElanco lifts 2026 outlook as innovation products drive Q3 growth
Raised full-year outlook: about 8% organic revenue growth, adjusted EBITDA growth of 17% at the midpoint and adjusted EPS of $1.17–$1.20. The prior quarter's organic revenue growth outlook was 6–7%.
What to watch on the call
Carried forward from the last transcriptAsk FN2 about ELAN next report
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Get the ELAN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Recent ELAN quarters
All ELAN earningsSources
- FN2 corporate events calendar, resolved from the earnings calendar feed
- FN2 earnings calendar analyst consensus
- Earnings call transcript analysis, FY2026 Q3
Methodology
The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.
Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.